American International Group, Inc. Biomea Fusion, Inc. Transaction History

American International Group, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$13.92 - $19.5 $1,169 - $1,638	-84 Reduced 0.85%	9,791 $146,000
Q4 2023 Feb 13, 2024	SELL	$8.37 - $19.8 $334 - $792	-40 Reduced 0.4%	9,875 $143,000
Q3 2023 Nov 13, 2023	BUY	$13.44 - $23.02 $4,744 - $8,126	353 Added 3.69%	9,915 $136,000
Q2 2023 Aug 04, 2023	BUY	$21.66 - $41.8 $207,112 - $399,691	9,562 New	9,562 $209,000
Q2 2022 Aug 12, 2022	SELL	$3.0 - $12.03 $32,289 - $129,478	-10,763 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$4.39 - $9.03 $3,323 - $6,835	-757 Reduced 6.57%	10,763 $48,000
Q4 2021 Feb 11, 2022	BUY	$7.22 - $12.72 $49,074 - $86,457	6,797 Added 143.91%	11,520 $86,000
Q3 2021 Nov 12, 2021	SELL	$10.0 - $15.99 $1,120 - $1,790	-112 Reduced 2.32%	4,723 $57,000
Q2 2021 Aug 13, 2021	BUY	$13.65 - $20.93 $65,997 - $101,196	4,835 New	4,835 $75,000

104

17.8M

1.68M

410K

Ticker BMEA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,290,600
Market Cap $189M
Description
Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.